DxTerity Diagnostics Revenue and Competitors

Compton, CA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • DxTerity Diagnostics's estimated annual revenue is currently $8.8M per year.(i)
  • DxTerity Diagnostics's estimated revenue per employee is $176,700

Employee Data

  • DxTerity Diagnostics has 50 Employees.(i)
  • DxTerity Diagnostics grew their employee count by -19% last year.

DxTerity Diagnostics's People

NameTitleEmail/Phone
1
Founder and CEOReveal Email/Phone
2
CFO and SVP Business Development, Co-FounderReveal Email/Phone
3
VP Product DevelopmentReveal Email/Phone
4
Chemical Hygiene OfficerReveal Email/Phone
5
Research AssociateReveal Email/Phone
6
Genomic Client ServicesReveal Email/Phone
7
Administrative AssistantReveal Email/Phone
8
Scientist, Product DevelopmentReveal Email/Phone
9
Molecular Laboratory TechnicianReveal Email/Phone
10
Laboratory Operations TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is DxTerity Diagnostics?

DxTerity is a privately owned biotechnology company located in Southern California. The company’s focus is to utilize the patented NEAT™ platform to provide a pathway to incorporate genetic testing—even complex gene signatures—into routine medical care.

keywords:N/A

N/A

Total Funding

50

Number of Employees

$8.8M

Revenue (est)

-19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

DxTerity Diagnostics News

2022-03-22 - LA Is Fertile Ground for Covid Testing Companies

Diagnostic roots · What's after Covid? · DxTerity Diagnostics Inc. · BiologyWorks Inc. · Applied BioCode Inc. · Curative LABS Inc. · Sameday...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.4M52-9%N/A
#2
$3.5M526%N/A
#3
$8.4M5227%N/A
#4
$14.5M5313%N/A
#5
$11.4M5315%N/A